Large-scale testing (Phase 3)Ended earlyNCT00529633
What this trial is testing
The Effect of Thalidomide in Suppression of the Systemic Inflammatory Response Syndrome in Hemodialysis Patients
Who this might be right for
Hypoalbuminemia
George A. Kaysen, M.D. 16